Medtronic (MDT) Receives FDA 510(k) Clearance for OsteoCool RF Ablation System

Go back to Medtronic (MDT) Receives FDA 510(k) Clearance for OsteoCool RF Ablation System

Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool(TM) RF Ablation System

January 13, 2016 8:01 AM EST

Minimally-Invasive Procedure Brings Relief to Patients
Suffering from Painful Spine Tumors

DUBLIN - January 13, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the OsteoCool(TM) RF Ablation System.  For physicians who treat patients with painful spine metastases, the OsteoCool System is the only cooled radiofrequency (RF) ablation technology that... More